Amy McKee, M.D., Chief Medical Officer and Global Head, Oncology Center of Excellence, Parexel


Four Key Trends for Identifying Regulator and Payer Evidence Needs in Oncology Drug Development

December 01, 2022

How to leverage novel trial designs and real-world data to support a cancer drug submission with an evidence strategy that is both approvable and reimbursable.